Laura Castellini

Pediatric Neurology Unit, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

24 publications 2003 – 2026 ORCID

What does Laura Castellini research?

Laura Castellini studies the effects of the cancer drug Sorafenib in liver cancer, specifically how it interacts with cancer cells and affects their metabolism. She discovered that when Sorafenib is combined with methods that block the breakdown of sugars (glycolysis), it becomes significantly more effective at killing cancer cells. Additionally, her research examines how stem cells derived from bone marrow and fat tissue can maintain their ability to renew themselves and what genes are involved in this process. This research can lead to improved therapies for various conditions, including those requiring regenerative medicine.

Key findings

  • Sorafenib alone had a limited effect on liver cancer cells, but when glucose was blocked or glycolysis was inhibited, the drug's effectiveness increased significantly, indicating a potential treatment strategy.
  • In her study on stem cells, Castellini identified 190 critical genes that play a role in maintaining the self-renewal capability of stem cells, particularly highlighting the function of the protein KLF4.
  • The research sheds light on the mechanisms that control whether stem cells change into different types of cells, which can enhance applications in regenerative therapies.

Frequently asked questions

Does Dr. Castellini study liver cancer?
Yes, Dr. Castellini focuses on liver cancer and investigates improving treatments for this condition.
What treatments has Dr. Castellini researched?
She has researched the cancer drug Sorafenib and its interactions with cancer cells, particularly in the context of enhancing its effectiveness.
Is Dr. Castellini's work relevant to patients needing regenerative therapies?
Yes, her research on stem cells can lead to advancements in regenerative medicine, which helps patients requiring tissue repair and replacement.

Publications in plain English

Pattern of Oculomotor Findings in Children with Attention Deficit/Hyperactivity Disorder in Relation to Methylphenidate Treatment.

2026

Journal of clinical medicine

Brogna C, Napoli V, Castellini L, Mirra F, Sestito S +8 more

Plain English
This study looked at how children with Attention-Deficit/Hyperactivity Disorder (ADHD) move their eyes and how this changes when they take a medication called methylphenidate (MPH). Researchers found that kids with ADHD often take longer to initiate eye movements, make more mistakes, and have more involuntary eye movements compared to those without ADHD. However, when treated with MPH, these children showed better control of their eye movements, with fewer errors and quicker responses. Who this helps: This helps children with ADHD and their doctors by providing insights into the effectiveness of treatments.

PubMed

Real-World Treatment Outcomes of an Artificial Tear Containing Arabinogalactan, Hyaluronic Acid and Trehalose Among Subjects with Dry Eye.

2025

Clinical ophthalmology (Auckland, N.Z.)

Bedei A, Rocha Cabrera P, Oliveira L, Castellini L, De Grazia G +1 more

Plain English
This study looked at how well a new type of artificial tear—made with ingredients like arabinogalactan, hyaluronic acid, and trehalose—works for people with dry eye disease. Out of 96 adults tested, 98% reported positive changes, including 39% feeling more comfortable and 13% seeing improvements in their vision after using the drops. This matters because it shows that this new treatment can significantly help manage symptoms for those suffering from dry eye. Who this helps: Patients with dry eye disease.

PubMed

Preoperative Opioid Use Increases Postoperative Opioid Demand, but Not Length of Stay After Spine Trauma Surgery.

2024

World neurosurgery

Castellini L, Barber J, Saigal R

Plain English
This study looked at how using opioids before surgery affects pain management and recovery time for patients with spine trauma. It found that patients who used opioids before their surgery needed 97.5 mg more opioids each day after surgery compared to those who did not use opioids, but there was no difference in how long they stayed in the hospital. This is important because it shows that while pre-surgery opioid use leads to higher painkiller needs post-surgery, it does not prolong recovery time in the hospital, potentially due to improved recovery methods. Who this helps: This helps doctors better manage pain and recovery for patients undergoing spine trauma surgery.

PubMed

Warm acclimation alters antioxidant defences but not metabolic capacities in the Antarctic fish,.

2022

Conservation physiology

O'Brien KM, Oldham CA, Sarrimanolis J, Fish A, Castellini L +3 more

Plain English
This study investigated how Antarctic fish adapt to warmer temperatures by examining their cellular and biochemical functions over periods of warm acclimation. Researchers found that while these fish showed minimal changes in metabolic functions, their antioxidant defenses decreased in the heart and certain muscles after being kept at 4°C for 22 days or 5°C for 42 days. This matters because understanding how these fish respond to rising ocean temperatures is crucial for predicting their survival as climate change continues to affect their habitat. Who this helps: This research benefits scientists studying climate change impacts on marine life and conservation efforts.

PubMed

The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling.

2021

Nature communications

Moon EJ, Mello SS, Li CG, Chi JT, Thakkar K +12 more

Plain English
This study focused on how certain genes regulated by low oxygen levels (hypoxia) in tumors contribute to cancer spread. Researchers found that a gene called MAFF is linked to increased invasion of breast cancer cells and is higher in patients with metastatic breast cancer. Blocking the function of IL11, a protein activated by MAFF, showed similar effects on reducing metastasis, indicating that targeting this pathway could be an important strategy in treating aggressive breast cancer. Who this helps: Patients with metastatic breast cancer.

PubMed

Free Radicals and Neonatal Brain Injury: From Underlying Pathophysiology to Antioxidant Treatment Perspectives.

2021

Antioxidants (Basel, Switzerland)

Martini S, Castellini L, Parladori R, Paoletti V, Aceti A +1 more

Plain English
This study focused on the damaging effect of free radicals on newborns' brains and how these can lead to brain injuries. Researchers found that specific treatments, like therapeutic hypothermia and magnesium sulfate, can help protect the brain by reducing oxidative stress. It’s important to identify and understand these free radicals so that better ways to protect newborns can be developed, ultimately leading to improved brain health in infants. Who this helps: This helps newborn patients and their doctors.

PubMed

Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations.

2020

Clinical cancer research : an official journal of the American Association for Cancer Research

Aguilera TA, Elghonaimy EA, Shehade H, Rafat M, Castellini L +8 more

Plain English
This study looked at how different types of tumor cells respond to radiation therapy in a model of triple-negative breast cancer. Researchers found that adding immune-responsive cells to otherwise unresponsive tumors made radiation therapy much more effective, increasing the cancer's response significantly. Specifically, using a CD40 antibody along with radiation improved both types of immune responses and helped prevent cancer from spreading in more advanced cases. Who this helps: This research benefits cancer patients, especially those with aggressive tumors that are difficult to treat.

PubMed

Hypoxia-inducible factor 2α is a negative regulator of osteoblastogenesis and bone mass accrual.

2019

Bone research

Merceron C, Ranganathan K, Wang E, Tata Z, Makkapati S +7 more

Plain English
This study looked at the role of a protein called HIF2 in bone formation. Researchers found that HIF2 actually slows down the creation of bone-forming cells, which can result in less bone mass. Specifically, they showed that in mice, higher levels of HIF2 reduce bone formation by affecting other important molecules involved in this process. This discovery is important because it changes the understanding of how hypoxia affects bones and suggests that targeting HIF2 could help treat conditions like osteoporosis or bone loss in aging patients. Who this helps: This helps patients suffering from osteoporosis and low bone mass conditions.

PubMed

Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.

2017

Annals of surgical oncology

Manders JB, Kuerer HM, Smith BD, McCluskey C, Farrar WB +25 more

Plain English
This study looked at how a special test called the 12-gene DCIS Score affects treatment decisions for women with ductal carcinoma in situ (DCIS), a type of early-stage breast cancer. It involved 127 women and found that after getting their DCIS Score results, doctors changed their recommendations about radiotherapy for 26.4% of the patients, with surgeons more likely to change their recommendations than radiation oncologists. This matters because it shows that understanding individual risk through the DCIS Score can help tailor treatments to better meet patients' needs and may reduce their anxiety about treatment decisions. Who this helps: This helps patients with ductal carcinoma in situ and their doctors.

PubMed

KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage.

2017

Nucleic acids research

Castellini L, Moon EJ, Razorenova OV, Krieg AJ, von Eyben R +1 more

Plain English
This study focused on how a gene called JMJD2B interacts with the p53 protein, which helps protect our cells from becoming cancerous when DNA is damaged. The researchers found that when JMJD2B is activated, it can reduce the activity of important genes that p53 usually turns on to respond to DNA damage. Specifically, when JMJD2B was increased, colon cancer cells grew faster, while blocking JMJD2B slowed down tumor growth. Who this helps: This research benefits cancer patients and doctors by providing new insights into how tumors may grow and potential targets for treatment.

PubMed

BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.

2017

Cancer discovery

Chiou SH, Risca VI, Wang GX, Yang D, Grüner BM +12 more

Plain English
Researchers studied pancreatic ductal adenocarcinoma (PDAC), a deadly form of cancer known for spreading rapidly. They found a specific group of cancer cells that are highly capable of metastasis, linked to a gene called BLIMP1, which is influenced by low oxygen levels (hypoxia) in the tumor environment. This discovery, which uncovers how certain cells develop their ability to spread, is crucial because it helps us understand the aggressive nature of PDAC and could lead to new treatment strategies. Who this helps: This benefits doctors and researchers working to treat pancreatic cancer patients.

PubMed

Reprogramming the immunological microenvironment through radiation and targeting Axl.

2016

Nature communications

Aguilera TA, Rafat M, Castellini L, Shehade H, Kariolis MS +10 more

Plain English
This study looked at how radiation therapy combined with immunotherapy affects breast cancer tumors in mice. Researchers found that two tumors could grow similarly, but only one responded well to the treatment; specifically, the treated tumor was cured while the other was not. The unresponsive tumor had high levels of a protein called Axl, which seems to block the immune system’s ability to attack the cancer. By removing Axl, the tumor grew slower and became more sensitive to radiation, suggesting targeting Axl might improve treatment outcomes. Who this helps: This benefits cancer patients, particularly those with certain types of breast cancer.

PubMed

Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells.

2015

Proceedings of the National Academy of Sciences of the United States of America

Finger EC, Castellini L, Rankin EB, Vilalta M, Krieg AJ +5 more

Plain English
This research studied how low oxygen levels in tumors affect a specific protein called AKAP12 variant 2, which is important for cell signaling. The findings showed that under low oxygen conditions, this protein changes the way certain signals within melanoma cells lead to increased movement and spreading of cancer, with specific changes observed in protein activity (although exact numbers were not provided). This is important because it helps explain how tumors can grow and spread more effectively, which could inform future treatments. Who this helps: Patients with metastatic melanoma.

PubMed

Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.

2015

Genes & development

Wu C, Rankin EB, Castellini L, Alcudia JF, LaGory EL +8 more

Plain English
The study examined how certain enzymes that sense oxygen levels affect bone health in mice. Researchers found that when they disabled specific enzymes (PHD1, PHD2, and PHD3) in cells that form bones, it caused an increase in bone growth and improved bone health, especially in mice that had their ovaries removed and were at risk for bone loss. This is important because it shows that oxygen levels in the bone environment play a crucial role in maintaining bone density and could lead to new treatments for bone diseases. Who this helps: This helps patients with osteoporosis and other bone diseases.

PubMed

Corrigendum: Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.

2015

Genes & development

Wu C, Rankin EB, Castellini L, Alcudia JF, LaGory EL +8 more

PubMed

The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.

2015

Scientific reports

Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C +8 more

Plain English
This study looked at how the cancer drug Sorafenib affects liver cancer cells. Researchers found that while Sorafenib alone had a limited effect on killing these cells, it caused damage to their mitochondria and increased harmful molecules that lead to cell death. When the supply of glucose was cut off or when a specific glycolysis blocker was used, the effectiveness of Sorafenib in killing the cancer cells increased significantly, highlighting a potential strategy to overcome resistance to the drug. Who this helps: This research helps cancer patients, especially those with liver cancer, by providing insights for more effective treatment options.

PubMed

The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells.

2014

Molecular and cellular biology

Razorenova OV, Castellini L, Colavitti R, Edgington LE, Nicolau M +5 more

Plain English
This study focused on the ARC gene, which helps cancer cells survive in low-oxygen environments. Researchers found that 65% of renal cancer tumors have high levels of ARC, while it is not present in normal kidney tissue. They discovered that without ARC, kidney cancer cells grow less and die more easily, highlighting its role in tumor survival, particularly when a gene called VHL is missing. Who this helps: Patients with renal cancer could benefit from strategies targeting the ARC gene for treatment.

PubMed

Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.

2014

Proceedings of the National Academy of Sciences of the United States of America

Rankin EB, Fuh KC, Castellini L, Viswanathan K, Finger EC +9 more

Plain English
This study looked at how a specific protein signaling pathway (GAS6/AXL) influences the spread of clear cell renal cell carcinoma (ccRCC), a type of kidney cancer. Researchers found that two proteins, HIF-1 and HIF-2, increase AXL levels in tumor cells, which then promotes their invasion and metastasis. When they blocked AXL in these cancer cells, the tumors became less aggressive, indicating that targeting AXL could help treat this type of cancer more effectively. Who this helps: Patients with clear cell renal cell carcinoma.

PubMed

Viral and antibody HEV prevalence in swine at slaughterhouse in Italy.

2011

Veterinary microbiology

Di Bartolo I, Ponterio E, Castellini L, Ostanello F, Ruggeri FM

Plain English
This study investigated the presence of the Hepatitis E virus (HEV) in pigs at a slaughterhouse in Northern Italy. Researchers found that 87% of the pigs had antibodies against HEV, and the virus itself was detected in 64.6% of the pigs, mostly in bile samples (51.1%). Understanding the prevalence of HEV in swine is important because it helps identify potential sources of infection for humans and reinforces food safety measures. Who this helps: This benefits patients, food safety regulators, and public health officials.

PubMed

Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation.

2011

Cytotherapy

Saulnier N, Puglisi MA, Lattanzi W, Castellini L, Pani G +5 more

Plain English
This study looked at two types of stem cells from bone marrow and fat tissue to understand how they stay “young” and can either keep renewing themselves or turn into different cell types. Researchers found 190 important genes that help control this process, highlighting the role of a protein called KLF4, which keeps the cells from changing into other types. Understanding these mechanisms is crucial because it can improve how we use these cells in medical treatments. Who this helps: This helps patients who could benefit from regenerative therapies.

PubMed

Variations in DNA elucidate molecular networks that cause disease.

2008

Nature

Chen Y, Zhu J, Lum PY, Yang X, Pinto S +17 more

Plain English
This study looked at how variations in DNA can disrupt gene networks and contribute to diseases like obesity and metabolic syndrome. Researchers found that three specific genes—Lpl, Lactb, and Ppm1l—are linked to obesity and play a role in disease caused by disruptions in a network of macrophage-enriched genes. This is important because it helps us understand that complex diseases like obesity are influenced by a combination of genetics and environmental factors, rather than just single genes alone. Who this helps: This helps patients dealing with obesity and metabolic syndrome, as well as doctors treating these conditions.

PubMed

Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma.

2008

Journal of neurochemistry

Gabellini C, Castellini L, Trisciuoglio D, Kracht M, Zupi G +1 more

Plain English
This study looked at how a protein called bcl-xL affects the expression of another protein called interleukin 8 (CXCL8) in glioblastoma cells, which are a type of brain cancer. Researchers found that bcl-xL increases CXCL8 levels by activating a signaling pathway involving a factor known as nuclear factor-kappa B (NF-kB). Specifically, when they increased bcl-xL, the amount of active NF-kB also rose, leading to higher CXCL8 production. Who this helps: This research benefits doctors and patients dealing with glioblastoma by providing insights into potential treatment approaches targeting these proteins.

PubMed

Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression.

2007

Molecular cancer research : MCR

Giorgini S, Trisciuoglio D, Gabellini C, Desideri M, Castellini L +4 more

Plain English
This study looked at how a protein called bcl-xL affects the formation of blood vessels in tumors. Researchers found that when bcl-xL was increased in human tumor cells, it boosted the production of a substance called CXCL8, which in turn improved the ability of endothelial cells (the cells that line blood vessels) to grow and develop into new blood vessels. This finding is important because it shows a new way that tumors can attract blood supply, which helps them grow and survive. Who this helps: This helps patients with tumors, as understanding this process can lead to better treatments.

PubMed

Styrene-catabolism regulation in Pseudomonas fluorescens ST: phosphorylation of StyR induces dimerization and cooperative DNA-binding.

2003

Biochemical and biophysical research communications

Leoni L, Ascenzi P, Bocedi A, Rampioni G, Castellini L +1 more

Plain English
This study looked at how a specific protein, StyR, in the bacteria Pseudomonas fluorescens ST, helps the bacteria break down styrene, a chemical used in making plastics. Researchers found that when StyR is modified (phosphorylated), it forms pairs (dimers) and binds more effectively to the DNA that starts the process of breaking down styrene, making this DNA interaction stronger and more efficient. This matters because understanding this process can aid in developing better bioremediation strategies to clean up environments contaminated with styrene. Who this helps: Patients and communities affected by environmental pollution.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.